Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amphastar Pharmaceuticals, Inc. - Common Stock (NQ:AMPH)

19.48 -0.05 (-0.26%)
Streaming Delayed Price Updated: 10:04 AM EDT, Mar 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 28,924
Open 19.37
Bid (Size) 19.48 (100)
Ask (Size) 19.64 (100)
Prev. Close 19.53
Today's Range 19.27 - 19.59
52wk Range 17.03 - 31.26
Shares Outstanding 48,081,433
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
3 of Wall Street’s Favorite Stocks We Think Twice About
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic... 
Via StockStory
News headline image
NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after easing crude oil prices helped lift investor sentiment and reduce inflation worries. ... 
Via StockStory
Topics Economy Stocks

Performance

YTD
-26.4%
-26.4%
1 Month
-29.6%
-29.6%
3 Month
-28.2%
-28.2%
6 Month
-26.1%
-26.1%
1 Year
-31.3%
-31.3%

More News

Read More
News headline image
AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know
Via StockStory
Topics Economy
Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Plummets After Q4 Earnings Miss Estimates ↗
Via Chartmill
Topics Earnings
News headline image
Generic Pharmaceuticals Stocks Q4 Highlights: Amphastar Pharmaceuticals (NASDAQ:AMPH)
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Why Amphastar Pharmaceuticals (AMPH) Shares Are Plunging Today
Via StockStory
Topics Economy
News headline image
Amphastar (AMPH) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings Supply Chain
News headline image
Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q4 CY2025 Revenue Estimates, Stock Drops 11.7%
Via StockStory
Topics Artificial Intelligence Supply Chain
Wondering what's happening in today's after-hours session? ↗
Via Chartmill
News headline image
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2025
Via ACCESS Newswire
News headline image
Amphastar Pharmaceuticals (AMPH) Reports Earnings Tomorrow: What To Expect
Via StockStory
Topics Artificial Intelligence
News headline image
Amphastar Announces FDA Approval for Ipratropium Bromide HFA
Via ACCESS Newswire
News headline image
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 26, 2026
Via ACCESS Newswire
News headline image
1 Value Stock on Our Watchlist and 2 We Turn Down
Via StockStory
Topics Retirement
News headline image
Amphastar Pharmaceuticals, Novavax, and Organon Shares Skyrocket, What You Need To Know
Via StockStory
Topics Economy
News headline image
3 Cash-Producing Stocks We Keep Off Our Radar
Via StockStory
News headline image
3 Stocks Under $50 with Warning Signs
Via StockStory
Topics Artificial Intelligence
News headline image
Why Amphastar Pharmaceuticals (AMPH) Stock Is Nosediving
Via StockStory
News headline image
2 Reasons to Avoid AMPH and 1 Stock to Buy Instead
Via StockStory
Topics Stocks Supply Chain
News headline image
1 Profitable Stock Worth Your Attention and 2 Facing Headwinds
Via StockStory
News headline image
Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Up Today
Via StockStory
News headline image
Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound
Via ACCESS Newswire
News headline image
3 Low-Volatility Stocks We Find Risky
Via StockStory
News headline image
Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference
Via ACCESS Newswire
News headline image
Amphastar Director Sells 16,679 Shares for $441,800 ↗
Via The Motley Fool
Topics Regulatory Compliance

Frequently Asked Questions

Is Amphastar Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Amphastar Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Amphastar Pharmaceuticals, Inc. - Common Stock trade on?
Amphastar Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Amphastar Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Amphastar Pharmaceuticals, Inc. - Common Stock is AMPH on the Nasdaq Stock Market
What is the current price of Amphastar Pharmaceuticals, Inc. - Common Stock?
The current price of Amphastar Pharmaceuticals, Inc. - Common Stock is 19.48
When was Amphastar Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Amphastar Pharmaceuticals, Inc. - Common Stock was at 03/27/26 10:04 AM ET
What is the market capitalization of Amphastar Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Amphastar Pharmaceuticals, Inc. - Common Stock is 936.63M
How many shares of Amphastar Pharmaceuticals, Inc. - Common Stock are outstanding?
Amphastar Pharmaceuticals, Inc. - Common Stock has 937M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.